Baker McKenzie M&A Partner Piotr “Pete” Korzynski has been recognized as one of Law360’s Top Attorneys Under 40 in Life Sciences. Pete is recognized for being a go-to attorney for complex mergers and acquisitions (M&A), including life sciences transactions, and for demonstrating strong technical skills and dedication to clients. Law360 editors have selected the 2025 Rising Stars from more than 1,100 submissions. Winners are attorneys under 40 whose career accomplishments belie their age.
Pete represents clients on both the buy- and sell-sides of negotiated and contested public and private M&A transactions. His experience covers a broad range of transaction structures as well as financing transactions in the public and private capital markets, including equity offerings and bond offerings. Law360’s profile of Pete highlights two notable transactions including Olink's USD 3.1 billion acquisition by Thermo Fisher Scientific and Lundbeck's USD 2.6 billion acquisition of Longboard Pharmaceuticals.
In addition to his client work, Pete has previously maintained an active pro bono practice. He has previously served as the Chair of the Sargent Shriver National Center on Poverty Law's Professionals' Council and, together with the National Immigrant Justice Center, successfully argued an asylum seeker's case in the Seventh Circuit Court of Appeals, which resulted in new case law around credibility findings in asylum cases.
Baker McKenzie’s life sciences transaction team is adept at handling all transactional needs, from small acquisitions of early-stage products to high-value transactions and complex global multijurisdictional projects. The team offers well-rounded advice in over 40 locations, providing clients with a keen understanding of the transactional landscape, industry trends, and regulatory outlook. This holistic perspective enables us to guide our clients through the complexities of the market, helping them navigate challenges and seize opportunities for growth.
Click here to read the profile.
Pete represents clients on both the buy- and sell-sides of negotiated and contested public and private M&A transactions. His experience covers a broad range of transaction structures as well as financing transactions in the public and private capital markets, including equity offerings and bond offerings. Law360’s profile of Pete highlights two notable transactions including Olink's USD 3.1 billion acquisition by Thermo Fisher Scientific and Lundbeck's USD 2.6 billion acquisition of Longboard Pharmaceuticals.
In addition to his client work, Pete has previously maintained an active pro bono practice. He has previously served as the Chair of the Sargent Shriver National Center on Poverty Law's Professionals' Council and, together with the National Immigrant Justice Center, successfully argued an asylum seeker's case in the Seventh Circuit Court of Appeals, which resulted in new case law around credibility findings in asylum cases.
Baker McKenzie’s life sciences transaction team is adept at handling all transactional needs, from small acquisitions of early-stage products to high-value transactions and complex global multijurisdictional projects. The team offers well-rounded advice in over 40 locations, providing clients with a keen understanding of the transactional landscape, industry trends, and regulatory outlook. This holistic perspective enables us to guide our clients through the complexities of the market, helping them navigate challenges and seize opportunities for growth.
Click here to read the profile.
Explore Our Newsroom